Revenues (Tables)

6 Months Ended

Jun. 30, 2017

Segment Reporting [Abstract]

Summary of net revenue

The Company’s net revenues consisted of the following for the three and six months ended June 30, 2017 and 2016:

	Three months ended June 30,				Six months ended June 30,
	2017		2016		2017		2016
Products:
Acetadote	$	1,723,984	$	1,895,199	$	2,989,424	$	3,732,661
Omeclamox-Pak	377,470		641,469		1,022,795		1,401,788
Kristalose	2,901,440		3,626,076		5,288,031		7,243,882
Vaprisol	276,705		421,800		961,253		789,848
Caldolor	1,052,917		631,893		1,865,944		1,703,861
Ethyol	2,091,836		—		5,758,644		—
Other	242,775		198,398		417,791		280,327
Total net revenues	$	8,667,127	$	7,414,835	$	18,303,882	$	15,152,367